Get started
Author

Benny J. Evison

Observed names: B. J. Evison, Benny Evison
ORCID: 0000-0001-5477-8721
Observed ORCID: 0000-0001-5477-8721
OpenAlex ID: A5009014107
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin
2015 · Mas Jaffri Masarudin, Suzanne M. Cutts, et al. · Nanotechnology Science and Applications · 363
Mitoxantrone, More than Just Another Topoisomerase II Poison
2015 · Benny J. Evison, Brad E. Sleebs, et al. · Medicinal Research Reviews · 269
A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove
2020 · Benny J. Evison, James T. Palmer, et al. · Bioorganic & Medicinal Chemistry · 54
PDF
Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent
2007 · B. J. Evison, O. C. Mansour, et al. · Nucleic Acids Research · 47
PDF
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity
2009 · Benny J. Evison, Rebecca A. Bilardi, et al. · Nucleic Acids Research · 33
PDF
A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo
2022 · Alexandra K. Suchowerska, Geurt Stokman, et al. · Journal of Lipid Research · 28
PDF
Formaldehyde-Activated Pixantrone Is a Monofunctional DNA Alkylator That Binds Selectively to CpG and CpA Doublets
2008 · Benny J. Evison, Francis Chiu, et al. · Molecular Pharmacology · 26
New Anthracenedione Derivatives with Improved Biological Activity by Virtue of Stable Drug−DNA Adduct Formation
2010 · Oula C. Mansour, Benny J. Evison, et al. · Journal of Medicinal Chemistry · 24
DNA binding by pixantrone
2010 · Najia Adnan, Damian P. Buck, et al. · Organic & Biomolecular Chemistry · 18
PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system
2023 · Jounghyun H. Lee, Kevin L. Shores, et al. · APL Bioengineering · 13
M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe
2011 · Benny J. Evison, Mile Pastuovic, et al. · Biochemical Pharmacology · 12
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
2016 · Mas Jaffri Masarudin, Suzanne Cutts, et al. · Nanotechnology Science and Applications · 10
PDF
The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts
2012 · Robert A. Forrest, Lonnie P. Swift, et al. · Cancer Chemotherapy and Pharmacology · 9
Design, synthesis, and DNA sequence selectivity of formaldehyde-mediated DNA-adducts of the novel N-(4-aminobutyl) acridine-4-carboxamide
2014 · Elizabeth A. Ankers, Benny J. Evison, et al. · Bioorganic & Medicinal Chemistry Letters · 6
Formaldehyde-activated WEHI-150 induces DNA interstrand crosslinks with unique structural features
2019 · Paul P. Pumuye, Benny J. Evison, et al. · Bioorganic & Medicinal Chemistry · 4
In vitro Transcription Assay for Resolution of Drug-DNA Interactions at Defined DNA Sequences
2009 · Benny J. Evison, Don R. Phillips, et al. · Methods in molecular biology · 4
An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells
2022 · Oula C. Mansour, Abraham Nudelman, et al. · Cancer Chemotherapy and Pharmacology · 2
Development of an automated assay for accelerated in vitro detection of DNA adduct-inducing and crosslinking agents
2021 · Jelena Medan, Brad E. Sleebs, et al. · Bioorganic & Medicinal Chemistry Letters · 2
Abstract C279: Novel anthracenedione derivatives demonstrating several potential modes of actions.
2013 · Paul P. Pumuye, Jelena E. Medan, et al. · Molecular Cancer Therapeutics
Abstract 3507: Facilitating pixantrone-induced DNA damage and subsequent cell kill through formaldehyde activation and improvements in drug design
2010 · Benny J. Evison, Oula C. Mansour, et al. · Cancer Research
Works count: 20
Citation count: 924
H-index: 11
I10-index: 12
Year
Topic
Type